Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
  • Log out
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

September 25, 2018; 91 (13) Article

Surgery and risk of Guillain-Barré syndrome

A French nationwide epidemiologic study

Jérémie Rudant, Axelle Dupont, Yann Mikaeloff, Francis Bolgert, Joël Coste, Alain Weill
First published August 24, 2018, DOI: https://doi.org/10.1212/WNL.0000000000006246
Jérémie Rudant
From Caisse Nationale de l'Assurance Maladie (J.R., A.D., J.C., A.W.), Direction de la Stratégie des Études et des Statistiques, Département Études en Santé Publique, Paris; Assistance Publique–Hôpitaux de Paris (Y.M.), Hôpital Bicêtre, Unité de Rééducation Neurologique Infantile, Bicêtre; Université Paris-Saclay (Y.M.), Université Paris-Sud, CESP, Inserm, Villejuif; and Assistance Publique–Hôpitaux de Paris (F.B.), Hôpital Pitié-Salpêtrière, Réanimation Neurologique, Neurologie 1, Paris, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Axelle Dupont
From Caisse Nationale de l'Assurance Maladie (J.R., A.D., J.C., A.W.), Direction de la Stratégie des Études et des Statistiques, Département Études en Santé Publique, Paris; Assistance Publique–Hôpitaux de Paris (Y.M.), Hôpital Bicêtre, Unité de Rééducation Neurologique Infantile, Bicêtre; Université Paris-Saclay (Y.M.), Université Paris-Sud, CESP, Inserm, Villejuif; and Assistance Publique–Hôpitaux de Paris (F.B.), Hôpital Pitié-Salpêtrière, Réanimation Neurologique, Neurologie 1, Paris, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yann Mikaeloff
From Caisse Nationale de l'Assurance Maladie (J.R., A.D., J.C., A.W.), Direction de la Stratégie des Études et des Statistiques, Département Études en Santé Publique, Paris; Assistance Publique–Hôpitaux de Paris (Y.M.), Hôpital Bicêtre, Unité de Rééducation Neurologique Infantile, Bicêtre; Université Paris-Saclay (Y.M.), Université Paris-Sud, CESP, Inserm, Villejuif; and Assistance Publique–Hôpitaux de Paris (F.B.), Hôpital Pitié-Salpêtrière, Réanimation Neurologique, Neurologie 1, Paris, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francis Bolgert
From Caisse Nationale de l'Assurance Maladie (J.R., A.D., J.C., A.W.), Direction de la Stratégie des Études et des Statistiques, Département Études en Santé Publique, Paris; Assistance Publique–Hôpitaux de Paris (Y.M.), Hôpital Bicêtre, Unité de Rééducation Neurologique Infantile, Bicêtre; Université Paris-Saclay (Y.M.), Université Paris-Sud, CESP, Inserm, Villejuif; and Assistance Publique–Hôpitaux de Paris (F.B.), Hôpital Pitié-Salpêtrière, Réanimation Neurologique, Neurologie 1, Paris, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joël Coste
From Caisse Nationale de l'Assurance Maladie (J.R., A.D., J.C., A.W.), Direction de la Stratégie des Études et des Statistiques, Département Études en Santé Publique, Paris; Assistance Publique–Hôpitaux de Paris (Y.M.), Hôpital Bicêtre, Unité de Rééducation Neurologique Infantile, Bicêtre; Université Paris-Saclay (Y.M.), Université Paris-Sud, CESP, Inserm, Villejuif; and Assistance Publique–Hôpitaux de Paris (F.B.), Hôpital Pitié-Salpêtrière, Réanimation Neurologique, Neurologie 1, Paris, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alain Weill
From Caisse Nationale de l'Assurance Maladie (J.R., A.D., J.C., A.W.), Direction de la Stratégie des Études et des Statistiques, Département Études en Santé Publique, Paris; Assistance Publique–Hôpitaux de Paris (Y.M.), Hôpital Bicêtre, Unité de Rééducation Neurologique Infantile, Bicêtre; Université Paris-Saclay (Y.M.), Université Paris-Sud, CESP, Inserm, Villejuif; and Assistance Publique–Hôpitaux de Paris (F.B.), Hôpital Pitié-Salpêtrière, Réanimation Neurologique, Neurologie 1, Paris, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Short Form
Citation
Surgery and risk of Guillain-Barré syndrome
A French nationwide epidemiologic study
Jérémie Rudant, Axelle Dupont, Yann Mikaeloff, Francis Bolgert, Joël Coste, Alain Weill
Neurology Sep 2018, 91 (13) e1220-e1227; DOI: 10.1212/WNL.0000000000006246

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
547

Share

  • Article
  • Figures & Data
  • Info & Disclosures
  • CME Course
Loading

Abstract

Objective To assess the association between Guillain-Barré syndrome (GBS) and recent surgery based on French nationwide data.

Methods Data were extracted from the French health administrative databases (SNIIRAM/PMSI). All patients hospitalized for GBS between 2009 and 2014 were identified by ICD-10 code G61.0 as main diagnosis. Patients previously hospitalized for GBS in 2006, 2007, and 2008 were excluded. Surgical procedures were identified from the hospital database. Hospitalizations for surgery with no infection diagnosis code entered during the hospital stay were also identified. The association between GBS and a recent surgical procedure was estimated using a case-crossover design. Case and referent windows were defined as 1–60 days and 366–425 days before GBS hospitalization, respectively. Analyses were adjusted for previous episodes of gastroenteritis and respiratory tract infection, identified by drug dispensing data.

Results Of the 8,364 GBS cases included, 175 and 257 patients had undergone a surgical procedure in the referent and case windows, respectively (adjusted odds ratio [OR] = 1.53, 95% confidence interval [CI]: 1.25–1.88). A slightly weaker association was observed for surgical procedures with no identified infection during the hospitalization (OR = 1.40, 95% CI: 1.12–1.73). Regarding the type of surgery, only surgical procedures on bones and digestive organs were significantly associated with GBS (OR and 95% CI = 2.78 [1.68–4.60] and 2.36 [1.32–4.21], respectively).

Conclusion In this large nationwide epidemiologic study, GBS was moderately associated with any type of recent surgery and was more strongly associated with bone and digestive organ surgery.

Glossary

CI=
confidence interval;
GBS=
Guillain-Barré syndrome;
ICD-10=
International Classification of Diseases, Tenth Revision;
OR=
odds ratio;
PMSI=
Programme de Médicalisation des Systèmes d'Information;
SNIIRAM=
Système National d'Information Interrégimes de l'Assurance Maladie

Guillain-Barré syndrome (GBS) is potentially life-threatening and typically occurs after gastroenteritis and respiratory tract infection.1 Surgery has also been suspected to trigger GBS on the basis of a large number of published case reports.2,–,32 According to the few published retrospective case series on this subject, between 5% and 19% of patients with GBS had undergone a surgical procedure during the 633,–,35 or 836 weeks preceding the onset of symptoms, which corresponds to a much higher surgery rate than in the general population.33,34 Several biological mechanisms have been proposed to explain the onset of GBS after surgery. It has been hypothesized that surgery may alter the balance of the immune system, resulting in transient immunosuppression,30 which would allow autoantibodies to promote an attack on peripheral nerves.33 This immunosuppression has also been hypothesized to promote subclinical infections that could predispose to the development of GBS.33 Intraoperative release of antigens and subsequent autoimmunization to these antigens has also been proposed as a possible sensitizing mechanism contributing to the development of GBS.31,37

The aim of this population-based epidemiologic study was to assess the association between GBS and recent surgery based on French nationwide health administrative databases.

Methods

A case-crossover design (main analysis) was performed using French health administrative databases.

Data sources

This study was based on the French National Health Insurance database (Système National d'Information Interrégimes de l'Assurance Maladie [SNIIRAM]) linked to the national hospital discharge database (Programme de Médicalisation des Systèmes d'Information [PMSI]) by means of a unique anonymous identifier allocated to each individual,38,39 providing detailed information on real-life management of all of the population living in France (approximately 65,000,000 people).

The SNIIRAM contains comprehensive individualized and anonymous data on all outpatient services reimbursed by French National Health Insurance, including drugs, physician visits, and laboratory or imaging investigations. This database now includes outpatient data from the entire population living in France but initially only included data from the 86% of the population covered by the general scheme (before 2010).39 The PMSI database describes all hospital stays in both public and private hospitals. It contains a main diagnosis and associated diagnoses coded according to the ICD-10. The main diagnosis corresponds to the disease justifying admission to the medical unit. The PMSI database also contains classifying procedures performed during the hospital stay, such as surgical procedures. This information is necessary to classify the patient in a given disease-related group. The PMSI database also contains information on expensive drugs administered in hospital, such as immunoglobulins.

Study population

All patients hospitalized in any medical unit for GBS between 2009 and 2014 in metropolitan France were identified from the PMSI database by the ICD-10 code G61.0 as the main diagnosis, as defined in a previous study by the same team.40 To be eligible for inclusion in this study, these patients had not been hospitalized with a GBS code (G61.0) (main or associated diagnoses) between 2006 and 2008. The date of GBS diagnosis (index date) was the date of admission of the first hospitalization for GBS over the study period.40 At least one health care claim between 36 and 13 months before the index date was also required to ensure that patient data were present in the SNIIRAM database throughout the observation period.39

Design

The association between GBS and recent surgery was estimated using a case-crossover design. This design only includes cases, which automatically controls for all time-invariant confounders41 such as genetic background. Each GBS case contributed to one case window (the “at risk” window) and one referent window, which were defined as 1–60 days and 366–425 days before the index date, respectively.

Exposure assessment

Surgical procedures during the case and referent windows were identified from the PMSI hospital discharge database and were considered globally and grouped according to the organs and tissues targeted by the procedure: eye (intraocular); heart, arteries, and veins; digestive organs; urinary system and reproductive organs; bones (vertebrae and limbs); periarticular anatomical structures and herniated disk; soft tissues; and other organs. The standard duration of the procedure, as determined by French National Health Insurance expert committees and used for billing of surgical procedures,42 was used. When several surgical procedures were performed on the same day, the maximum duration was considered. Hospitalizations for surgery with no infection diagnosis code entered during the hospital stay (main and associated diagnoses) were also distinguished from hospitalizations associated with infection codes (data available from Dryad, table e-1, doi.org/10.5061/dryad.h9t1675), as some infections, such as cholecystitis, may require surgery, and other infections, such as surgical site infections, can complicate the procedure.

Covariate assessment

Clinically diagnosed gastroenteritis and acute respiratory tract infections occurring during the case and referent windows were identified by the dispensing of drugs (retail pharmacies) used for their treatment43,44 and covered by French National Health Insurance (some antidiarrheals, intestinal adsorbents, antipropulsives and dehydration salts for gastroenteritis, and extended-spectrum penicillins, cephalosporins, macrolides, pristinamycin, and certain cough and cold preparations for respiratory tract infections). Additional infections during the case and referent windows were identified from the PMSI hospital discharge database (main diagnosis as intestinal infectious diseases [A01–A09] or acute respiratory tract infections [J00–J22, J85.0–J85.2, J86]), which added very few infection events.

Statistical analysis

Conditional logistic regression was used to estimate matched odds ratios (ORs) and 95% confidence intervals (CIs) of the association between GBS and recent surgery. Analyses were adjusted for gastroenteritis and respiratory tract infection exposure in the case and referent windows.

Sensitivity analyses

Analyses were also performed by considering 30-day and 90-day case and referent windows, and after restriction to cases treated with immunoglobulins or plasmapheresis. A case-time control design was performed to take potential exposure time trends into account.45 For this purpose, 10 controls for each case were randomly sampled from the SNIIRAM database, from all beneficiaries with at least one health care claim during the calendar year of diagnosis of the index case. Controls were matched to cases by year and month of birth, and department of residence. They were also required to have at least one health care claim during the calendar year preceding the year of diagnosis of the matched GBS case. The case and referent windows of the controls were the same as those of their matched case (i.e., 1–60 days and 366–425 days before the index date, respectively).

Standard protocol approvals, registrations, and patient consents

This study was approved by the French data protection agency (Commission Nationale de l'Informatique et des Libertés) (regulatory decision DE-2011-078).

Data availability

The present data cannot be shared, for legal reasons. Applications to access the French health insurance claims data must be submitted to the Institut National des Données de Santé (www.indsante.fr/).

Results

Of the 8,944 GBS incident cases identified in metropolitan France between 2009 and 2014, 8,364 had at least one health care claim 36 to 13 months before the date of diagnosis of GBS, and constituted the study population. The mean age of this study population was 51 years, and 57% were men. Twenty-nine percent of patients were hospitalized in intensive care units and 13% required mechanical ventilation (table 1). Immunoglobulins were administered in 76% of patients and plasmapheresis was performed in 3.5% of patients. Three percent of patients died during the 3 months following the first admission to hospital for GBS. A seasonal variation was observed with a peak in winter. As expected, GBS was associated with a recent history of gastroenteritis and respiratory tract infection (table 2).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1

Study population and characteristics of GBS cases

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 2

Association between Guillain-Barré syndrome and infections during the previous 60 days (case-crossover design)

One hundred seventy-five (2.1%) and 257 (3.1%) GBS cases had undergone a surgical procedure in the referent and case windows, respectively (table 3). Of interest, the winter peak was no longer observed among the 257 GBS cases with a history of recent surgery (case distribution: winter: 26.1% [n = 67 cases]; spring: 26.1% [n = 67 cases]; summer: 22.2% [n = 57 cases]; and autumn: 25.7% [n = 66 cases]). Data available from Dryad (table e-2, doi.org/10.5061/dryad.h9t1675) indicate the procedures performed during the referent and case windows. The crude OR of the association between GBS and surgery during the previous 60 days was 1.48 (1.22–1.80) (table 4). The OR was slightly higher after adjustment for gastroenteritis and respiratory tract infection (OR = 1.53 [1.25–1.88]; table 4) and slightly lower when only considering surgical procedures with no infection coded during the hospitalization (adjusted OR = 1.40 [1.12–1.73]). Surgical procedures on digestive organs and bones were significantly associated with GBS (OR = 2.36 [1.32–4.21] and OR = 2.78 [1.68–4.60], respectively) (table 5). These associations were not limited to a group of organs (limbs and vertebrae for bone surgery, and digestive tract, biliary tract, liver, and other organs for digestive surgery) and also remained significant for procedures with no infection coded during the hospitalization (data available from Dryad, table e-3, doi.org/10.5061/dryad.h9t1675). Other categories of surgery (eye, heart/arteries/veins, urinary system and reproductive organs, periarticular anatomical structures, soft tissues, and other) were not associated with an increased risk of GBS (table 5), although a positive association was observed with female genital organ surgery (OR = 3.34 [1.12–9.92], p = 0.03; data available from Dryad, table e-3, doi.org/10.5061/dryad.h9t1675). Overall, the OR of the association with surgery increased with the duration of the procedure, reaching 2.22 (1.48–3.34) for procedures lasting more than 120 minutes (table 6). However, the duration of the procedure was strongly correlated with the type of surgery. In particular, 52% of patients in whom the surgical procedure lasted more than 120 minutes in the case window underwent a procedure on bones or digestive organs (42 of 80 patients), whereas this percentage was only 12% for procedures lasting less than 60 minutes (11 of 93 patients) (data available from Dryad, table e-4, doi.org/10.5061/dryad.h9t1675). Of note, the “other organs” surgery subgroup was significantly associated with GBS for procedures lasting more than 120 minutes (OR = 2.94 [1.15–7.53], p = 0.02) (data available from Dryad, table e-4, doi.org/10.5061/dryad.h9t1675). Long surgical procedures include lung surgery and transplantations, which were more frequent in the case window than in the referent window (data available from Dryad, table e-3, doi.org/10.5061/dryad.h9t1675).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 3

Number of cases of Guillain-Barré syndrome according to the presence of surgery in case and referent windows

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 4

Association between Guillain-Barré syndrome and surgery during the previous 60 days (case-crossover design)

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 5

Association between Guillain-Barré syndrome and surgery during the previous 60 days (case-crossover design) for each main group of surgery

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 6

Association between surgery during the previous 60 days and Guillain-Barré syndrome (case-crossover design), according to the standard duration of the procedure

No significant heterogeneity for the association between GBS and surgery was observed by age group (p for interaction = 0.64), considering groups younger than 40 years (OR = 1.23 [0.75–2.01]), 40–59 years (OR = 1.62 [1.04–2.52]), and 60 years and older (OR = 1.60 [1.24–2.06]), although the association was slightly less marked among the younger patients.

Sensitivity analysis

The choice of 30-day and 90-day case and referent windows resulted in ORs close to those observed with a 60-day window (any surgery: adjusted ORs equal to 1.66 [1.25–2.19] for 30 days and 1.54 [1.30–1.83] for 90 days). Besides, the association between GBS and surgery was still positive and significant among patients treated with immunoglobulins or plasmapheresis, with ORs of the association equal to 1.80 (1.42–2.27) for any surgery and 3.86 (1.84–8.09) and 3.12 (1.79–5.43) for surgery on digestive organs and bone surgery, respectively (data available from Dryad, table e-5, doi.org/10.5061/dryad.h9t1675). The other 6 main groups of surgery were not significantly associated with GBS.

Only minor variations in the prevalence of exposure were observed between the referent window and the case window among control subjects (2.8% increase of surgical procedures over the 12-month period). The case-time control ORs for the association between GBS and any surgery was therefore only slightly modified (crude OR = 1.44 [1.16–1.77], adjusted OR = 1.49 [1.20–1.86]).

Discussion

In this large nationwide study including more than 8,000 cases, GBS was moderately associated with any type of recent surgery. The association remained significant for surgical procedures with no identified infection during the hospitalization. GBS was more strongly associated with bone and digestive organ surgery.

Population-based epidemiologic studies investigating the relationships between GBS and recent surgery are rare. Based on case series data, Gensick et al.33 and Sipilä and Soilu-Hänninen34 estimated a high relative risk of GBS after surgery compared to the general population (13.1 [95% CI = 5.68–30.3]33 and 6.3 [95% CI = 4.2–9.5],34 respectively). In the present study, the association between GBS and any type of surgery was much lower than that reported by Gensick et al.33 and Sipilä and Soilu-Hänninen.34

The main strength of this study is that it was conducted on a prospectively collected comprehensive database covering more than 65 million inhabitants.38,39 Cases were therefore included on a nationwide basis, excluding the possibility of any selection bias attributable to inclusion of GBS cases from one or only a few hospitals (recruitment that could be directly or indirectly related to a recent history of surgery). Furthermore, the large sample size of the study allowed investigation of the duration of the procedure and the type of surgery. Surgical procedures are classifying procedures, meaning that they must be precisely recorded for the hospital to receive full National Health Insurance payment. Data were also adjusted for proxies for common gastroenteritis and respiratory tract infections based on drug dispensing data from the SNIIRAM database. Adjustment for these cofactors slightly increased the OR, which is not surprising, as onset of a common infection would be expected to postpone elective surgery. A self-controlled design was used, allowing time-invariant confounders to be considered over the study period. The case-crossover design is particularly relevant for studying transient exposure, such as surgery, and rare events.41 The case-time control design was also used to take into account a potential time trend in the population exposure prevalence.45 A 1-year lag between the referent and case windows was chosen to take into account the effect of seasonality of GBS and surgery.

A main limitation of this study is the impossibility to confirm GBS cases based on chart review, because the database is irreversibly anonymized. Some validation studies from other countries have shown that the positive predictive value was not perfect for GBS algorithms based on discharge diagnosis codes, although it was improved by considering only the main or primary diagnosis,46,47 as in the present study. Moreover, GBS epidemiologic patterns and characteristics of the hospitalization for GBS derived from the French health administrative data40 were in line with the data reported in several studies from Europe and North America.40 Another limitation is that the identification of infectious events was based on drug dispensing and hospitalization diagnosis codes, without the support of clinical charts or patient interviews. Some infections may therefore not have been identified. However, the present study still confirmed the well-known association between GBS and recent gastroenteritis or respiratory tract infection. We observed a highly significant association for digestive organs and bone surgery (p values of 0.0037 and <0.0001, respectively). Significant associations were also observed for female genital organ surgery, and long surgical procedures in the “other organs” subgroup. However, because of multiple testing, these 2 results could also be explained by chance, as the p values were equal to only 0.03 and 0.02. The results derived from this case-crossover design could be biased when the exposure of interest increases mortality rates, as this would lead to an apparent higher prevalence of exposure in the case window compared to the referent window among selected individuals, because only survivors reach the index date and are therefore included in the study. However, postoperative mortality is low in France,48,49 and is therefore unable to explain the magnitude of the significant associations.

GBS is typically caused by an autoimmune attack on peripheral nerves. However, the mechanisms linking GBS to surgery remain unclear. The present study supports a mechanism that is not specific of a particular surgical procedure, in line with previously formulated hypotheses. These include the role of a transient immunosuppression following surgery,33 altering the balance of the immune system and promoting subclinical infections, or the intraoperative release of antigens and subsequent autoimmunization to these antigens.31,37

In this first population-based epidemiologic study on the relationship between GBS and recent surgery, we report a moderate association between GBS and any type of surgery. Stronger associations were observed with bone and digestive organ surgery. Further research is needed to elucidate the mechanisms by which surgery may increase the risk of GBS.

Author contributions

J.R., A.D., Y.M., F.B., J.C., and A.W. made substantial contributions to the conception and design of the study. A.D. and J.R. performed data management and statistical analyses. J.R. wrote the first draft of the paper. J.R., A.D., Y.M., F.B., J.C., and A.W. contributed to interpretation of the data, revised the manuscript, and approved the final manuscript.

Study funding

This research was funded by the Caisse Nationale de l'Assurance Maladie (French National Health Insurance Fund).

Disclosure

The authors report no disclosures relevant to the manuscript. Go to Neurology.org/N for full disclosures.

Footnotes

  • ↵* These authors contributed equally to this work.

  • Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.

  • CME Course: NPub.org/cmelist

  • Received February 19, 2018.
  • Accepted in final form June 28, 2018.
  • © 2018 American Academy of Neurology

References

  1. 1.↵
    1. Willison HJ,
    2. Jacobs BC,
    3. van Doorn PA
    . Guillain-Barré syndrome. Lancet 2016;388:717–727.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Bulsara KR,
    2. Baron PW,
    3. Tuttle-Newhall JE,
    4. Clavien PA,
    5. Morgenlander J
    . Guillain-Barré syndrome in organ and bone marrow transplant patients. Transplantation 2001;71:1169–1172.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. El-Sabrout RA,
    2. Radovancevic B,
    3. Ankoma-Sey V,
    4. Van Buren CT
    . Guillain-Barré syndrome after solid organ transplantation. Transplantation 2001;71:1311–1316.
    OpenUrlPubMed
  4. 4.↵
    1. Koc M,
    2. Ozalp N,
    3. Zulfikaroglu B
    . Major surgery with Guillain-Barré syndrome: a case report. J Int Med Res 2002;30:601–604.
    OpenUrlPubMed
  5. 5.↵
    1. Chouillard E,
    2. Fingerhut A
    . Guillain-Barré syndrome following oesophagectomy. ANZ J Surg 2004;74:915–916.
    OpenUrlPubMed
  6. 6.↵
    1. Puertas-Muñoz I,
    2. Miranda-Lloret P,
    3. Lagares A,
    4. Ramos-González A
    . Guillain-Barré syndrome following resection of glioblastoma multiforme [in Spanish]. Rev Neurol 2004;39:1137–1139.
    OpenUrlPubMed
  7. 7.↵
    1. Foubert-Samier A,
    2. Penchet G,
    3. Yekhlef F,
    4. Lemasson G,
    5. Sibon I
    . Guillain-Barré syndrome secondary to cranial surgery: direct or fortuitous relationship? [in French]. Neurochirurgie 2005;51:604–606.
    OpenUrlPubMed
  8. 8.↵
    1. Kuok CH,
    2. Tsai PS,
    3. Hsu YW,
    4. Ko YP,
    5. Huang CJ,
    6. Chen CC
    . Postoperative delayed respiratory failure caused by Guillain-Barré syndrome: a case report. Acta Anaesthesiol Taiwan 2007;45:43–46.
    OpenUrlPubMed
  9. 9.↵
    1. Zhang L,
    2. Arrington S,
    3. Keung YK
    . Guillain-Barré syndrome after transplantation. Leuk Lymphoma 2008;49:291–297.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Algahtani H,
    2. Moulin DE,
    3. Bolton CF,
    4. Abulaban AA
    . Guillain-Barré syndrome following cardiac surgery: difficult diagnosis in the intensive care unit. Neurosciences 2009;14:374–378.
    OpenUrl
  11. 11.↵
    1. Aluka KJ,
    2. Turner PL,
    3. Fullum TM
    . Guillain-Barré syndrome and postbariatric surgery polyneuropathies. JSLS 2009;13:250–253.
    OpenUrlPubMed
  12. 12.↵
    1. Campbell AJ,
    2. McKinlay K,
    3. Scott NB
    . Guillain-Barré syndrome after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2009;23:82–83.
    OpenUrlPubMed
  13. 13.↵
    1. Lee MC,
    2. Campbell R,
    3. Born C
    . Guillain-Barré syndrome after failed pelvic fracture fixation. J Trauma 2009;67:E132–E135.
    OpenUrlPubMed
  14. 14.↵
    1. Olivier N,
    2. Laribi H,
    3. Pages M,
    4. Camu W,
    5. Juntas Morales R
    .Recurrent Guillain-Barré syndrome after surgery [in French]. Rev Neurol 2010;166:644–647.
    OpenUrl
  15. 15.↵
    1. Papantoni E,
    2. Sakorafas GH,
    3. Zouros E,
    4. Peros G
    . Guillain-Barré syndrome following total gastrectomy/esophagectomy: a very rare and dramatic post-operative complication with a favourable outcome. ANZ J Surg 2010;80:858.
    OpenUrlPubMed
  16. 16.↵
    1. Cheng J,
    2. Kahn DE,
    3. Wang MY
    . The acute motor-sensory axonal neuropathy variant of Guillain-Barré syndrome after thoracic spine surgery. J Neurosurg Spine 2011;15:605–609.
    OpenUrlPubMed
  17. 17.↵
    1. Heyworth BE,
    2. Fabricant PD,
    3. Pizzurro MM,
    4. Beksac B,
    5. Salvati EA
    . Guillain-Barré syndrome mimicking nerve injury after total hip arthroplasty. HSS J 2011;7:286–289.
    OpenUrlPubMed
  18. 18.↵
    1. Cingoz F,
    2. Tavlasoglu M,
    3. Kurkluoglu M,
    4. Sahin MA
    . Guillain-Barré syndrome after coronary artery bypass surgery. Interact Cardiovasc Thorac Surg 2012;15:918–919.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Miscusi M,
    2. Currà A,
    3. Della Rocca C,
    4. Missori P,
    5. Petrozza V
    . Acute motor-sensory axonal neuropathy after cervical spine surgery. J Neurosurg Spine 2012;17:82–85.
    OpenUrlPubMed
  20. 20.↵
    1. Battaglia F,
    2. Sevy A,
    3. Moyse E,
    4. Roche PH
    . Guillain-Barré syndrome following severe head trauma and spine surgery. Rev Neurol 2013;169:166–168.
    OpenUrl
  21. 21.↵
    1. Landais AF
    . Rare neurologic complication of bariatric surgery: acute motor axonal neuropathy (AMAN), a severe motor axonal form of the Guillain Barré syndrome. Surg Obes Relat Dis 2014;10:e85–e87.
    OpenUrl
  22. 22.↵
    1. Plojoux J,
    2. Buffard-Morel M,
    3. Ducamp D, et al
    . Guillain-Barré syndrome after lung lobectomy: is there any relationship? Ann Thorac Surg 2014;97:e133–e134.
    OpenUrl
  23. 23.↵
    1. Boghani Z,
    2. Livingston AD,
    3. Simpson EP,
    4. Holman PJ,
    5. Grossman RG
    . Acute onset of Guillain-Barré syndrome after elective spinal surgery. World Neurosurg 2015;84:376–379.
    OpenUrl
  24. 24.↵
    1. Huang SL,
    2. Qi HG,
    3. Liu JJ,
    4. Huang YJ,
    5. Xiang L
    . A rare complication of spine surgery: Guillain-Barré syndrome. World Neurosurg 2015;84:697–701.
    OpenUrl
  25. 25.↵
    1. Ishaque N,
    2. Khealani BA,
    3. Shariff AH,
    4. Wasay M
    . Guillain-Barré syndrome (demyelinating) six weeks after bariatric surgery: a case report and literature review. Obes Res Clin Pract 2015;9:416–419.
    OpenUrl
  26. 26.↵
    1. Kim DJ,
    2. Lee J,
    3. Lee J,
    4. Kim MR,
    5. Ha IH
    . Guillain-Barré syndrome mistaken for a common spinal disorder: a case report. Altern Ther Health Med 2015;21:64–67.
    OpenUrl
  27. 27.↵
    1. Shakuri-Rad J,
    2. Gavin PW,
    3. Todd SP, et al
    . Guillain-Barré syndrome after robotically assisted laparoscopic prostatectomy: first case report. Urol Case Rep 2015;3:44–46.
    OpenUrl
  28. 28.↵
    1. Degterev DA,
    2. Suponeva NA,
    3. Bodunova NA, et al
    . A rare complication of bariatric surgery: polyradiculoneuropathy as a type of Guillain-Barré syndrome [in Russian]. Ter Arkh 2016;88:79–83.
    OpenUrl
  29. 29.↵
    1. Hekmat M,
    2. Ghaderi H,
    3. Foroughi M,
    4. Mirjafari SA
    . Guillain-Barré syndrome after coronary artery bypass graft surgery: a case report. Acta Med Iran 2016;54:76–78.
    OpenUrl
  30. 30.↵
    1. Chen EY,
    2. Stratton C,
    3. Mercer B,
    4. Hohler A,
    5. Tannoury TY,
    6. Tannoury C
    . Guillain-Barré syndrome after elective spinal surgery. J Am Acad Orthop Surg 2017;25:587–593.
    OpenUrl
  31. 31.↵
    1. Rashid A,
    2. Kurra S,
    3. Lavelle W
    . Guillain-Barré syndrome after revision lumbar surgery: a case report. Cureus 2017;9:e1393.
    OpenUrl
  32. 32.↵
    1. Sahai N,
    2. Hwang KS,
    3. Emami A
    . Guillain-Barré syndrome following elective spine surgery. Eur Spine J 2017;26:6–8.
    OpenUrl
  33. 33.↵
    1. Gensicke H,
    2. Datta AN,
    3. Dill P,
    4. Schindler C,
    5. Fischer D
    . Increased incidence of Guillain-Barré syndrome after surgery. Eur J Neurol 2012;19:1239–1244.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Sipilä JO,
    2. Soilu-Hänninen M
    . The incidence and triggers of adult-onset Guillain-Barré syndrome in southwestern Finland 2004–2013. Eur J Neurol 2015;22:292–298.
    OpenUrl
  35. 35.↵
    1. Yang B,
    2. Lian Y,
    3. Liu Y,
    4. Wu BY,
    5. Duan RS
    . A retrospective analysis of possible triggers of Guillain-Barré syndrome. J Neuroimmunol 2016;293:17–21.
    OpenUrlCrossRef
  36. 36.↵
    1. Hurwitz ES,
    2. Holman RC,
    3. Nelson DB,
    4. Schonberger LB
    . National surveillance for Guillain-Barré syndrome: January 1978–March 1979. Neurology 1983;33:150–157.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    1. Steiner I,
    2. Argov Z,
    3. Cahan C,
    4. Abramsky O
    . Guillain-Barré syndrome after epidural anesthesia: direct nerve root damage may trigger disease. Neurology 1985;35:1473–1475.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    1. Bezin J,
    2. Duong M,
    3. Lassalle R, et al
    . The national healthcare system claims databases in France, SNIIRAM and EGB: powerful tools for pharmacoepidemiology. Pharmacoepidemiol Drug Saf 2017;26:954–962.
    OpenUrlPubMed
  39. 39.↵
    1. Tuppin P,
    2. Rudant J,
    3. Constantinou P, et al
    . Value of a national administrative database to guide public decisions: from the système national d'information interrégimes de l'Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France. Rev Epidemiol Sante Publique 2017;65(suppl 4):S149–S167.
    OpenUrlPubMed
  40. 40.↵
    1. Delannoy A,
    2. Rudant J,
    3. Chaignot C,
    4. Bolgert F,
    5. Mikaeloff Y,
    6. Weill A
    . Guillain-Barré syndrome in France: a nationwide epidemiological analysis based on hospital discharge data (2008–2013). J Peripher Nerv Syst 2017;22:51–58.
    OpenUrl
  41. 41.↵
    1. Maclure M
    . The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol 1991;133:144–153.
    OpenUrlPubMed
  42. 42.↵
    Caisse nationale de l'Assurance maladie des travailleurs Salariés. Méthodologie de hierarchisation du travail médical des actes techniques CCAM [online]. 2002. Available at: ameli.fr/accueil-de-la-ccam/regles-de-facturation/presentation-de-la-ccam/methodologie-de-hierarchisation-du-travail-medical.php. August 16, 2018.
  43. 43.↵
    1. Bounoure F,
    2. Beaudeau P,
    3. Mouly D,
    4. Skiba M,
    5. Lahiani-Skiba M
    . Syndromic surveillance of acute gastroenteritis based on drug consumption. Epidemiol Infect 2011;139:1388–1395.
    OpenUrlCrossRefPubMed
  44. 44.↵
    1. Pivette M,
    2. Mueller JE,
    3. Crépey P,
    4. Bar-Hen A
    . Drug sales data analysis for outbreak detection of infectious diseases: a systematic literature review. BMC Infect Dis 2014;14:604.
    OpenUrl
  45. 45.↵
    1. Suissa S
    . The case-time-control design. Epidemiology 1995;6:248–253.
    OpenUrlCrossRefPubMed
  46. 46.↵
    1. Bogliun G,
    2. Beghi E
    , Guillain-Barré Syndrome Registry Study Group. Validity of hospital discharge diagnoses for public health surveillance of the Guillain-Barré syndrome. Neurol Sci 2002;23:113–117.
    OpenUrlCrossRefPubMed
  47. 47.↵
    1. Funch D,
    2. Holick C,
    3. Velentgas P, et al
    . Algorithms for identification of Guillain-Barré syndrome among adolescents in claims databases. Vaccine 2013;31:2075–2079.
    OpenUrl
  48. 48.↵
    1. Gillion JF
    . Is crude postoperative mortality rate a relevant criterion of the efficiency of a surgical team? Prospective study of 11,756 patients' postoperative course [in French]. Ann Chir 2005;130:400–406.
    OpenUrlPubMed
  49. 49.↵
    1. Pearse RM,
    2. Moreno RP,
    3. Bauer P, et al
    . Mortality after surgery in Europe: a 7 day cohort study. Lancet 2012;380:1059–1065.
    OpenUrlCrossRefPubMed

Disputes & Debates: Rapid online correspondence

  • Author response to Dr. Steiner
    • Jérémie Rudant, Epidemiologist, Caisse Nationale de l’Assurance Maladie
    • Axelle Dupont, Epidemiologist, Caisse Nationale de l’Assurance Maladie
    • Yann Mikaeloff, Neurologist, Hopital Bicetre, Unite de Reeducation Neurologique Infantile
    • Francis Bolgert, Neurologist, Hopital Pitie-Salpetriere, Reanimation Neurologique, Neurologie 1
    • Joël Coste, Epidemiologist, Caisse Nationale de l’Assurance Maladie
    • Alain Weill, Epidemiologist, Caisse Nationale de l’Assurance Maladie
    Submitted January 08, 2019
  • Guillain-Barré syndrome following surgery
    • Israel Steiner, Neurologist, Rabin Medical Center
    Submitted December 18, 2018
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Glossary
    • Methods
    • Results
    • Discussion
    • Author contributions
    • Study funding
    • Disclosure
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
  • CME Course

More Online

CME Course

Topics Discussed

  • Guillain-Barre syndrome
  • Risk factors in epidemiology

Alert Me

  • Alert me when eletters are published
Neurology: 96 (14)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2021 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise